INTERNATIONAL PATENT: BEIJING WINSUNNY PHARMACEUTICAL CO., LTD, 北京福元医药股份有限公司 FILES APPLICATION FOR "DOUBLE-STRANDED RIBONUCLEIC ACID FOR INHIBITING INHBE GENE EXPRESSION AND MODIFIER THEREOF, CONJUGATE THEREOF AND USE THEREOF"

GENEVA, March 16 -- BEIJING WINSUNNY PHARMACEUTICAL CO., LTD (NO.8, Guangyuan East Street, Tongzhou Industrial Development Zone,Tongzhou District, Beijing 101113), 北京福元医药股份有限公司 (中国北京市通州区通州工业开发区广源东街8号) filed a patent application (PCT/CN2025/125277) for "DOUBLE-STRANDED RIBONUCLEIC ACID FOR INHIBITING INHBE GENE EXPRESSION, AND MODIFIER THEREOF, CONJUGATE THEREOF AND USE THEREOF" on Sep 29, 2025. With publication no. WO/2026/052140, the details related to the patent application was published on Mar 12, 2026.

Notably, the ...